DeVries, Todd

Bristol-Myers Squibb (United States) · Juno Therapeutics (United States)

1 paper on CoChatORCID 0009-0006-5645-9373

Most cited papers

Verified
Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) with relapsed/refractory multiple myeloma (RRMM): update of the phase 1/2 EVOLVE study (NCT03430011).
Mailankody, S., Jakubowiak, A. J., Htut, M., Costa, L. J., Lee, K., Ganguly, S., Kaufman, J. L., Siegel, D. S. D., Bensinger, W., Cota, M., et al. (2020) · Journal of Clinical Oncology
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 126

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free